Literature DB >> 31419487

Local outbreak of Clostridioides difficile PCR-Ribotype 018 investigated by multi locus variable number tandem repeat analysis, whole genome multi locus sequence typing and core genome single nucleotide polymorphism typing.

Cécile Gateau1, Stéphanie Deboscker2, Jeanne Couturier3, Thomas Vogel4, Elise Schmitt4, Joris Muller2, Céline Ménard5, Béatrice Turcan2, Rabab Syed Zaidi6, Anlyata Youssouf6, Thierry Lavigne2, Frédéric Barbut3.   

Abstract

The prevalence of Clostridioides difficile PCR-ribotype (RT) 018 is low in Europe but variations are observed across countries. We report here the first RT 018-related outbreak in France that took place in 4 geriatric units (GU) in Strasbourg, France. From January to December 2017, 38 patients were diagnosed with C. difficile infection (CDI). Strains were first characterized by PCR ribotyping: 19 out of 38 (50%) strains belonged to RT 018. These strains as well as 12 RT 018 isolated in other French healthcare facilities and 2 strains of RT 018 isolated in the GU in 2015 were characterized by multi locus variable-number tandem repeat (VNTR) analysis (MLVA), whole genome multi locus sequence typing (wgMLST) and core genome single nucleotide polymorphism typing (cgSNP). The MLVA indicated that 15 out of 19 epidemic strains of RT 018 were included in 2 Clonal Complexes (CC). Four RT 018 strains from the outbreak did not belong to the CC. The wgMLST and cgSNP typing analysis revealed a single CC that included 19 strains from the geriatric unit (17 from GU in 2017 and 2 from GU in 2015) and 4 strains (33%) from other healthcare facilities (HCF). Our results suggest that a specific RT 018 clone has spread in the geriatric unit and has evolved slowly over time. MLVA, wgMLST and cgSNP typing results provided fairly consistent information but wgMLST and cgSNP typing better separated epidemic strains from non-epidemic strains. Compared to wgMLST, the cgSNP typing did not provide additional information.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  C. difficile; MLVA; Outbreak; PCR-Ribotyping; cgSNP; wgMLST

Mesh:

Substances:

Year:  2019        PMID: 31419487     DOI: 10.1016/j.anaerobe.2019.102087

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  5 in total

1.  Comparison of Whole-Genome Sequence-Based Methods and PCR Ribotyping for Subtyping of Clostridioides difficile.

Authors:  A Baktash; J Corver; C Harmanus; W K Smits; W Fawley; M H Wilcox; N Kumar; D W Eyre; A Indra; A Mellmann; E J Kuijper
Journal:  J Clin Microbiol       Date:  2021-12-15       Impact factor: 11.677

2.  Evaluation of a Combined Multilocus Sequence Typing and Whole-Genome Sequencing Two-Step Algorithm for Routine Typing of Clostridioides difficile.

Authors:  Mini Kamboj; Tracy McMillen; Mustafa Syed; Hoi Yan Chow; Krupa Jani; Anoshe Aslam; Jennifer Brite; Brian Fanelli; Nur A Hasan; Manoj Dadlani; Lars Westblade; Ahmet Zehir; Matthew Simon; N Esther Babady
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

3.  Rapid Open-Source SNP-Based Clustering Offers an Alternative to Core Genome MLST for Outbreak Tracing in a Hospital Setting.

Authors:  Judit Szarvas; Mette Damkjaer Bartels; Henrik Westh; Ole Lund
Journal:  Front Microbiol       Date:  2021-04-01       Impact factor: 5.640

4.  Characterization of a Clostridioides difficile outbreak caused by PCR ribotype 046, associated with increased mortality.

Authors:  Cecilia Magnusson; Sara Mernelius; Malin Bengnér; Torbjörn Norén; Lena Serrander; Sophie Forshell; Andreas Matussek
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

5.  Whole Genome Multi-Locus Sequence Typing and Genomic Single Nucleotide Polymorphism Analysis for Epidemiological Typing of Pseudomonas aeruginosa From Indonesian Intensive Care Units.

Authors:  Manisha Goyal; Andreu Coello Pelegrin; Magali Jaillard; Yulia Rosa Saharman; Corné H W Klaassen; Henri A Verbrugh; Juliëtte A Severin; Alex van Belkum
Journal:  Front Microbiol       Date:  2022-07-14       Impact factor: 6.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.